Glendon E. French III - Mar 1, 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact
Stock symbol
LUNG
Transactions as of
Mar 1, 2024
Transactions value $
-$63,003
Form type
4
Date filed
3/5/2024, 06:15 PM
Previous filing
Feb 16, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$10.8K -1.19K -0.11% $9.06 1.12M Mar 1, 2024 Direct F1, F2
transaction LUNG Common Stock Sale -$16.5K -1.82K -0.16% $9.06 1.12M Mar 1, 2024 Direct F3
transaction LUNG Common Stock Sale -$35.8K -3.95K -0.35% $9.06 1.12M Mar 1, 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 Includes 2,368 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.